Loading chat...
OK HB2047
Bill
Status
5/14/2025
Primary Sponsor
Preston Stinson
Click for details
AI Summary
HB 2047 Summary
-
Creates the "Emerson Kate Cole Act" amending Oklahoma school medication policies for asthma, anaphylaxis, and cystic fibrosis treatment
-
Requires school employees to call 911 immediately if Epinephrine is administered to a student and to notify parents of any student experiencing a possible allergic reaction
-
Schools may stock Epinephrine injectors and inhalers with spacers or holding chambers (minimum two of each per site) in secure locations, but are not required to do so
-
Mandates State Board of Education develop model policies requiring annual training for teachers and school employees on food allergies, recognizing anaphylaxis, and administering Epinephrine, to be completed before school year begins or upon hiring
-
Allows trained school nurses or employees to administer Epinephrine with parent permission (but without health care provider order) to students in anaphylactic reaction, and inhalers to students in respiratory distress
Legislative Description
Schools; creating the Emerson Kate Cole Act; school medication policies; eliminating references to epinephrine injectors; eliminating reference to certain training program; parent permissions; 911; mandating parent notifications; allergic reactions; model policies; annual training.
Last Action
Becomes law without Governor's signature 05/14/2025
5/14/2025